A
Menu
First published November 06, 2025 Application Aachen patent C – Chemistry & metallurgy

CHEMICAL PROBES

Espacenet Family 91966829

Abstract

Provided is a compound of any one of formulae I to X, or a salt, solvate or precursor thereof as defined herein (I); (II); (III); (IV); (V); (VI); (VII); (VIII); (IX); (X). Also, pharmaceutical compositions comprising said compounds; combinations of two or more of said compounds; a kit comprising said compounds; the use of said compounds in chemical proteomics; and methods of identifying binding of one or more proteins in a biological sample to one or more of said compounds.

Inventors 4

  1. van der Stelt, Marcelis
  2. Joel Rüegger Aachen author as filed: Rüegger, Joel
  3. Stephan M. Hacker Aachen author as filed: Hacker, Stephan Michael
  4. Bosman, Robertus Eduardus Johannes

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

Cited papers 11 in the database

Non-patent literature as cited (31)
  • - CUESTATAUNTON, ANNU. REV. BIOCHEM., vol. 88, 2019, pages 365 - 81
  • - ZANON, P. R. A. ET AL.: "ChemRxiv", CAMBRIDGE: CAMBRIDGE OPEN ENGAGE, 2021
  • - PARKERPRATT, CELL, vol. 180, 20 February 2020 (2020-02-20)
  • - L. W. DEADY, SYN. COMM., vol. 7, 1977, pages 509 - 514
  • - MEISSNER, F.GEDDES-MCALISTER, J.MANN, M. ET AL., NAT REV DRUG DISCOV, vol. 21, 2022, pages 637 - 654
  • - CONSORTIUM TUBATEMAN AMARTIN M-J ET AL.: "UniProt: the Universal Protein Knowledgebase in 2023", NUCLEIC ACIDS RES, vol. 51, 2022, pages D523 - D531, Retrieved from the Internet <URL:https:doi.org/10.1093/nar/glac1052>
  • - BHULLAR, K. S. ET AL.: "Kinase-targeted cancer therapies: progress, challenges and future directions", MOL. CANCER, vol. 17, 2018, pages 48, XP055769399, DOI: 10.1186/s12943-018-0804-2
  • - JENNINGS, D. ET AL.: "Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease", SCI. TRANSL. MED., vol. 14, 2022, pages eabj2658
  • - SATO, S. ET AL.: "Essential function for the kinase TAK1 in innate and adaptive immune responses", NAT. IMMUNOL., vol. 6, 2005, pages 1087 - 1095, XP002465094, DOI: 10.1038/ni1255
  • - ROSKOSKI, R: "Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update", PHARMACOL. RES., vol. 200, 2024, pages 107059
  • - COHEN, P.ALESSI, D. R.: "Kinase Drug Discovery - What's Next in the Field?", ACS CHEM. BIOL., vol. 8, 2013, pages 96 - 104
  • - FERGUSON, F. M.GRAY, N. S.: "Kinase inhibitors: the road ahead", NAT. REV. DRUG DISCOV., vol. 17, 2018, pages 353 - 377, XP055757317, DOI: 10.1038/nrd.2018.21
  • - KLAEGER, S. ET AL.: "The target landscape of clinical kinase drugs", SCIENCE, vol. 358, 2017, pages eaan4368, XP055433333, DOI: 10.1126/science.aan4368
  • - PATRICELLI, M. P. ET AL.: "Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates", BIOCHEMISTRY, vol. 46, 2007, pages 350 - 358, XP055241228, DOI: 10.1021/bi062142x
  • - SHI, H.ZHANG, C.-J.CHEN, G. Y. J.YAO, S. Q.: "Cell-Based Proteome Profiling of Potential Dasatinib Targets by Use of Affinity-Based Probes", J. AM. CHEM. SOC., vol. 134, 2012, pages 3001 - 3014, XP055318803, DOI: 10.1021/ja208518u
  • - GREINER, J. V.GLONEK, T.: "Intracellular ATP Concentration and Implication for Cellular Evolution", BIOLOGY, vol. 10, 2021, pages 1166
  • - VASTA, J. D. ET AL.: "Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement", CELL CHEM BIOL, vol. 25, 2018, pages 206 - 214
  • - SAVITSKI, M. M. ET AL.: "Tracking cancer drugs in living cells by thermal profiling of the proteome", SCIENCE, vol. 346, 2014, pages 1255784, XP055193718, DOI: 10.1126/science.1255784
  • - VASTA, J. D. ET AL.: "Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement", CELL CHEM. BIOL., vol. 25, 2018, pages 206 - 214
  • - ROBERS, M. B. ET AL.: "et al. Single tracer-based protocol for broad-spectrum kinase profiling in live cells with NanoBRET", STAR PROTOC, vol. 2, 2021, pages 100822
  • - ZHAO, Q. ET AL.: "Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 139, 2017, pages 680 - 685, XP055696664, DOI: 10.1021/jacs.6b08536
  • - YANG, T. ET AL.: "Reversible lysine-targeted probes reveal residence time-based kinase selectivity", NAT CHEM BIOL, vol. 1-8, 2022
  • - LEUNG, C. O. N. ET AL.: "Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma", NAT. COMMUN., vol. 14, 2023, pages 6699
  • - ROODEN, E. J. VAN ET AL.: "Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification", NAT PROTOC, vol. 13, 2018, pages 752 - 767
  • - RAPPSILBER, J.MANN, M.ISHIHAMA, Y.: "Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips", NAT. PROTOC., vol. 2, 2007, pages 1896 - 1906, XP055642417, DOI: 10.1038/nprot.2007.261
  • - SKOWRONEK, P. ET AL.: "Rapid and In-Depth Coverage of the (Phospho-)Proteome With Deep Libraries and Optimal Window Design for dia-PASEF", MOL CELL PROTEOMICS, vol. 21, 2022, pages 100279
  • - DEMICHEV, V.MESSNER, C. B.VERNARDIS, S. I.LILLEY, K. S.RALSER, M.: "DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput", NAT METHODS, vol. 17, 2020, pages 41 - 44, XP036979562, DOI: 10.1038/s41592-019-0638-x
  • - VAN DER ZOUWEN ANTONIE J. ET AL: "Modular Approaches to Synthesize Activity- and Affinity-Based Chemical Probes", FRONTIERS IN CHEMISTRY, vol. 9, 15 April 2021 (2021-04-15), pages .644811, XP093106753, DOI: 10.3389/fchem.2021.644811
  • - YANG PENGYU ET AL: "Activity-Based Protein Profiling: Recent Advances in Probe Development and Applications", CHEMBIOCHEM, vol. 16, no. 5, 4 February 2015 (2015-02-04), Hoboken, USA, pages 712 - 724, XP055809537, ISSN: 1439-4227, DOI: 10.1002/cbic.201402582
  • - CUESTA ADOLFO ET AL: "Lysine-Targeted Inhibitors and Chemoproteomic Probes", ANNU. REV. BIOCHEM, vol. 88, 11 January 2019 (2019-01-11), pages 365 - 381, XP055772324, DOI: 10.1146/annurev-biochem-061516-
  • - ALLEGRETTI PAUL A ET AL: "Generation of highly potent DYRK1A-dependent inducers of human [beta]-Cell replication via Multi-Dimensional compound optimization", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 28, no. 1, 11 November 2019 (2019-11-11), XP085966898, ISSN: 0968-0896, [retrieved on 20191111], DOI: 10.1016/J.BMC.2019.115193

Cited patents 1

WO2023196991A1